Ebola and the need for restructuring pharmaceutical incentives

Abstract

The West African Ebola epidemic has created market demand for the rapid development of vaccines and therapeutics, but the current global patent system does not ensure that the poor will have access to these products.

Keywords

• ebola
• pharmaceutical incentives